Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- 2800 Mechelen
- Most recent report
- 6-K, filed Sep 8, 2026
- Filings on record
- 535 filings
- On EDGAR
- CIK 1421876
- Filer status
- Large accelerated filer
Financials 8 of 437
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 1, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 25, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 25, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 25, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 18, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 12, 2026
Prospectuses and Registrations 8 of 22
- 424B3 Prospectus supplement for an offering May 8, 2026
- S-8 Registration statement for an employee plan Dec 10, 2025
- S-8 Registration statement for an employee plan Nov 20, 2024
- S-8 Registration statement for an employee plan Dec 4, 2023
- S-8 Registration statement for an employee plan Dec 12, 2022
- S-8 Registration statement for an employee plan Oct 26, 2021
- S-8 Registration statement for an employee plan Oct 9, 2020
- S-8 Registration statement for an employee plan May 24, 2019
Ownership 8 of 43
- SCHEDULE 13G Large holder reported a passive stake Jun 23, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 29, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 28, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended May 19, 2025
- SCHEDULE 13D Large holder reported an active stake Feb 14, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Jan 10, 2025
- SC 13G/A Large holder reported a passive stake, amended Nov 12, 2024
- SC 13D/A Large holder reported an active stake, amended Oct 8, 2024
Other 8 of 33
Everything here comes from Lakefront Biotherapeutics NV's own filings on SEC EDGAR. The filing list is rechecked every hour.